UM
(Note: the search results are based on claimed items)

Browse/Search Results:  1-7 of 7 Help

Filters        
Selected(0)Clear Items/Page:    Sort:
Neurocognitive dysfunction in subjects at clinical high risk for psychosis: A meta-analysis Journal article
JOURNAL OF PSYCHIATRIC RESEARCH, 2018,Volume: 103,Page: 38-45
Authors:  Zheng, Wei;  Zhang, Qing-E.;  Cai, Dong-Bin;  Ng, Chee H.;  Ungvari, Gabor S.;  Ning, Yu-Ping;  Xiang, Yu-Tao
Favorite  |  View/Download:15/0  |  Submit date:2018/10/30
Schizophrenia  Psychosis  Clinical High Risk For Psychosis  Neurocognitive Function  Mccb  Meta-analysis  
Rhythmic Low-field magnetic stimulation may improve depression by increasing brain derived neurotropic factor Journal article
CNS spectrums., 2018
Authors:  Xiao L;  Correll CU;  Feng L;  Xiang YT;  Feng Y;  Hu CQ;  Li R;  Wang G
Favorite  |  View/Download:2/0  |  Submit date:2019/01/09
Major Depressive Disorder  Rhythmic Magnetic Stimulation  Brain-derived Neurotrophic Factor  Moderator  Mediator  
Adjunctive metformin for antipsychotic-related hyperprolactinemia: A meta-analysis of randomized controlled trials Journal article
JOURNAL OF PSYCHOPHARMACOLOGY, 2017,Volume: 31,Issue: 5,Page: 625-631
Authors:  Zheng, Wei;  Yang, Xin-Hu;  Cai, Dong-Bin;  Ungvari, Gabor S.;  Ng, Chee H.;  Wang, Nan;  Ning, Yu-Ping;  Xiang, Yu-Tao
Favorite  |  View/Download:22/0  |  Submit date:2018/10/30
Prolactin  Metformin  Schizophrenia  Meta-analysis  
Clozapine augmentation with antiepileptic drugs for treatment-resistant schizophrenia: A meta-analysis of randomized controlled trials Journal article
Journal of Clinical Psychiatry, 2017,Volume: 78,Issue: 5,Page: e498-e505
Authors:  Zheng W.;  Xiang Y.-T.;  Yang X.-H.;  Xiang Y.-Q.;  De Leon J.
Favorite  |  View/Download:9/0  |  Submit date:2018/12/18
Amantadine for antipsychotic-related weight gain: Meta-analysis of randomized placebo-controlled trials Journal article
Journal of Clinical Psychopharmacology, 2017,Volume: 37,Issue: 3,Page: 341-346
Authors:  Zheng W.;  Wang S.;  Ungvari G.S.;  Ng C.H.;  Yang X.-H.;  Gu Y.-H.;  Li M.;  Xiang Y.-Q.;  Xiang Y.-T.
Favorite  |  View/Download:1/0  |  Submit date:2018/12/18
Amantadine  Meta-analysis  Schizophrenia  Weight Gain  
Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: Results from a randomized, placebo-controlled 4-week study Journal article
Psychological Medicine, 2016,Volume: 46,Issue: 3,Page: 623
Authors:  Hu Y.-D.;  Xiang Y.-T.;  Fang J.-X.;  Zu S.;  Sha S.;  Shi H.;  Ungvari G.S.;  Correll C.U.;  Chiu H.F.K.;  Xue Y.;  Tian T.-F.;  Wu A.-S.;  Ma X.;  Wang G.
Favorite  |  View/Download:6/0  |  Submit date:2018/10/30
Escitalopram  Ketamine  Key Words Efficacy  Major Depression  Response  Tolerability  
A comparison of cognitive-behavioral therapy, antidepressants, their combination and standard treatment for Chinese patients with moderate-severe major depressive disorders Journal article
Journal of Affective Disorders, 2014,Volume: 152-154,Issue: 1,Page: 262-267
Authors:  Zu S.;  Xiang Y.-T.;  Liu J.;  Zhang L.;  Wang G.;  Ma X.;  Kilbourne A.M.;  Ungvari G.S.;  Chiu H.F.K.;  Lai K.Y.C.;  Wong S.Y.S.;  Yu D.S.F.;  Li Z.-J.
Favorite  |  View/Download:1/0  |  Submit date:2018/12/18
China  Cognitive-behavioral Therapy  Major Depressive Disorders  Outpatients